Sclerifuma 120 mg (Dimethyl fumarate)

Sclerifuma 120 mg (Dimethyl Fumarate) is a prescription medication indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults. It helps reduce the frequency of relapses and delays the progression of physical disability associated with MS.

Dimethyl fumarate, the active ingredient, has immunomodulatory and anti-inflammatory properties, which help protect nerve cells from immune-mediated damage. It is typically administered orally in a 120 mg dosage, often taken twice daily as per physician guidance.

Common side effects may include flushing, gastrointestinal discomfort, and mild nausea, which usually decrease over time. Regular monitoring of blood counts and liver function is recommended during treatment.

Sclerifuma offers a convenient oral therapy option for patients seeking an effective way to manage relapsing MS and improve long-term neurological health.